AOD-9604 10 mg

Strength 10 mg / 3 mLPurity HPLCForm Pre-filled penCOA Per batch

A modified fragment of growth hormone (hGH 176–191) studied for stimulating lipolysis and inhibiting lipogenesis without the glucose effects of full-length GH.

Researched directions

Lipolysis and fat-metabolism research
Body-composition endpoints
Lipogenesis-inhibition models
Metabolic-rate studies

Request access to order Ask the lab

Available to verified researchers. Pricing and the batch Certificate of Analysis are shared on request.

About AOD-9604

AOD-9604 is the C-terminal fragment of growth hormone studied for its fat-metabolising properties — promoting lipolysis and reducing lipogenesis — without affecting blood glucose or IGF-1 in research models.

Features

AOD-9604 is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, ready-to-use subcutaneous delivery format that removes reconstitution and simplifies repeat-dose study designs. Each pen is prepared from HPLC-verified material, dose-marked on the barrel, and shipped refrigerated with a Certificate of Analysis available per batch.

Handling & compliance

This pre-filled pen is intended strictly for in-vitro and laboratory research. It is not a drug, supplement, or medical device, and is not for human or veterinary use. Store refrigerated at 2–8 °C, protect from light, and follow accepted laboratory practice; exact specifications for your lot are listed on its Certificate of Analysis.

Back to catalogue

Pen

Metabolic · GHRH

Tesamorelin 10 mg

The 10 mg GHRH-analog pen for GH-axis and visceral-fat research.

View 10 mg

Pen

Metabolic · NNMT inhibitor

5-Amino-1MQ 20 mg

A selective NNMT inhibitor studied for fat-mass reduction and NAD⁺ research.

View 20 mg

Pen

Metabolic · ERR agonist

SLU-PP-332 10 mg

An ERR agonist studied as an exercise mimetic for endurance research.